InvestorRoom | Kitov Pharmaceuticals http://kitovpharma.investorroom.com/ Kitov Pharma Provides Corporate Update and Reports First Half 2018 Financial Results http://kitovpharma.investorroom.com/news-releases?item=68 Wed, 29 Aug 2018 03:04:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=68 Kitov Announces Settlement of Shareholder Class Action Litigation http://kitovpharma.investorroom.com/news-releases?item=67 Mon, 30 Jul 2018 19:47:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=67 Kitov to Host Business Update Conference Call on Monday, July 2 http://kitovpharma.investorroom.com/news-releases?item=66 Wed, 27 Jun 2018 03:23:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=66 Kitov Announces Positive Pre-clinical Data from NT219 Demonstrating its Dose-Dependent Anti-Tumor Efficacy http://kitovpharma.investorroom.com/news-releases?item=65 Results in PDX model of pancreatic cancer supports planned IND for NT219 Fri, 15 Jun 2018 09:31:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=65 Kitov Announces Pricing of $8,150,000 Registered Direct Offering http://kitovpharma.investorroom.com/news-releases?item=63 Fri, 01 Jun 2018 08:40:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=63